GSK Investigational Site

Logroño 26006

0 studies enrolling now · 5 studies all time

What they study most

Infection, Human Immunodeficiency Virus I, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Severe Acute Respiratory Syndrome

Studies at this site

• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease — Completed
• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed